# FibroGen China Anemia Holdings, Ltd. — Form D/A

FibroGen China Anemia Holdings, Ltd. of GRAND CAYMAN, E9, a company, filed a Form D amendment with the SEC on 2013-01-14. $6.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-01-14
- Form: D/A
- Accession: 0001555069-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Amount sold: $6.7M
- Minimum investment: $2K
- Investors: 53
- Date of first sale: 2012-07-11
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-181913

## Issuer

- Name: FibroGen China Anemia Holdings, Ltd.
- CIK: 0001555069
- Entity type: Corporation
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2012
- Address: C/O OGIER FIDUCIARY SERVICES (CAYMAN)LTD, GRAND CAYMAN, E9, KY1-9007
- Phone: 4159781200

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Thomas B Neff | Director | San Francisco, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2012-07-27](https://search.stillhousedata.com/formd/0001555069-12-000002) | D | $6.0M | $6.0M |

## More

- [CIK 1555069 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1555069&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001555069-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.